C. Rasmussen

VEGF gene therapy for coronary artery disease and peripheral vascular disease.

H. Rasmussen, J. Macko, C. Rasmussen, 2002, Cardiovascular radiation medicine.

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

D. Stewart, S. Archer, J. Grégoire, 2006, Gene Therapy.

A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities

R. Weichselbaum, N. Senzer, J. Nemunaitis, 2004, Clinical Cancer Research.

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.

R. Weichselbaum, N. Senzer, J. Nemunaitis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Angiogenic gene therapy strategies for the treatment of cardiovascular disease.

H. Rasmussen, Grant Yonehiro, J. Macko, 2002, Current opinion in molecular therapeutics.

TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene

D. Brough, R. Weichselbaum, C. King, 2002, Cancer Gene Therapy.